Hodgkin's Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
  • +1 more
2022-04-07
Apr 7, 2022
M
Recruiting
  • Hodgkin's Lymphoma
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • Pembrolizumab
  • Torrance, California
  • +24 more
2022-04-07
Apr 7, 2022
N
Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
2022-04-04
Apr 4, 2022
U
Active, not recruiting
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
  • CAR.CD30 T cells
  • Chapel Hill, North Carolina
  • +2 more
2022-03-16
Mar 16, 2022
U
Suspended
  • Hodgkin's Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-08
Mar 8, 2022
M
Recruiting
  • Breast Cancer
  • +2 more
  • surveys
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2022-03-01
Mar 1, 2022
R
Recruiting
  • AML - Acute Myeloid Leukemia
  • +5 more
  • T-allo10
  • Palo Alto, California
    Lucile Packard Children's Hospital
2022-02-02
Feb 2, 2022
B
Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • autologous CAR.CD30 EBV specific-CTLs
  • Houston, Texas
  • +1 more
2022-02-04
Feb 4, 2022
I
Terminated
  • Hodgkin's Lymphoma
  • histone deacetylase inhibitor (ITF2357)
  • Milan, Italy
    Istituto Nazionale per lo studio e la cura dei Tumori
2022-01-18
Jan 18, 2022
V
Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
2021-12-21
Dec 21, 2021
U
Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
2021-12-03
Dec 3, 2021
M
Active, not recruiting
  • Hodgkin's Lymphoma
  • Diffuse Large B-cell Lymphoma
    • Tampa, Florida
    • +8 more
    2021-12-16
    Dec 16, 2021
    M
    B
    Recruiting
    • Hodgkin's Lymphoma
    • Non-Hodgkin Lymphoma
    • CAR T Cells
    • +2 more
    • Houston, Texas
    • +1 more
    2021-11-02
    Nov 2, 2021
    U
    Active, not recruiting
    • Hodgkin's Lymphoma
    • +8 more
    • Reduced intensity haplodentical stem cell transplant
    • Myeloablative haploidentical stem cell transplant
    • Birmingham, United Kingdom
    • +11 more
    2021-09-27
    Sep 27, 2021
    S
    Active, not recruiting
    • Hodgkin's Lymphoma
    • Palo Alto, California
    • +5 more
    2021-08-20
    Aug 20, 2021
    T
    Completed
    • Non-Hodgkin's Lymphoma
    • +3 more
    • Sarasota, Florida
    • +6 more
    2021-08-20
    Aug 20, 2021
    M
    Active, not recruiting
    • Hodgkin's Lymphoma
    • brentuximab vedotin (SGN-35)
    • Brentuximab Vedotin (SGN-35)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    2021-06-11
    Jun 11, 2021
    I
    Completed
    • Hodgkin's Lymphoma
    • Milano, Italy
      Istituto Nazionale per la Cura e lo Studio dei Tumori
    2021-04-20
    Apr 20, 2021
    W
    Active, not recruiting
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • Morgantown, West Virginia
      West Virginia University Hospitals Mary Babb Randolph Cancer Cen
    2021-04-06
    Apr 6, 2021
    U
    Active, not recruiting
    • Hodgkin's Lymphoma
    • Cardiac Magnetic Resonance Imaging
    • Echocardiogram
    • Jacksonville, Florida
      University of Florida Health Proton Therapy Institute
    2021-02-25
    Feb 25, 2021
    W
    Completed
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • New York, New York
      Weill Cornell Medical College
    2021-02-01
    Feb 1, 2021
    M
    Completed
    • Hodgkin's Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2020-12-10
    Dec 10, 2020
    H
    Recruiting
    • Hodgkin's Lymphoma
    • Auto CAR-T
    • +2 more
    • Shijiazhuang, Hebei, China
      Hematology Department, Hebei Medical University Fourth Hospital
    2020-12-24
    Dec 24, 2020